U.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
BUZZ-U.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie Oct 9 (Reuters) - US stock indexes advanced broadly on Friday and were on pace to clock weekly gains, as investors looked forward to the earnings season next week. .N
At 13:30 EDT, the Dow Jones Industrial Average .DJI was up 0.74% at 51,609.03. The S&P 500 .SPX was up 0.54% at 7,807.08, and the Nasdaq Composite .IXIC was up 0.54% at 27,339.85.
The top three S&P 500 .PG.INX percentage gainers:
** Humana Inc. HUM.N, up 12.4%
** Crown Castle Inc CCI.N, up 11.9%
** Moderna, Inc. MRNA.OQ, up 11.4%
The top three S&P 500 .PL.INX percentage losers:
** T-Mobile US Inc TMUS.OQ, down 13.3%
** AT&T Inc. T.N, down 9.4%
** Verizon Communications Inc VZ.N, down 9.3%
The top three NYSE .PG.N percentage gainers:
** Concord Medical Services Holdings Ltd CCM.N, up 20.6%
** Ginkgo Bioworks Holdings, Inc. DNA.N, up 17.5%
** Mogu Inc MOGU.N, up 13.7%
The top three NYSE .PL.N percentage losers:
** Cable One Inc CABO.N, down 32.8%
** Braemar Hotels & Resorts Inc BHR.N, down 13.4%
** AT&T Inc. T.N, down 9.4%
The top three Nasdaq .PG.O percentage gainers:
** WF Holding Ltd WFF.OQ, up 354.1%
** Veea Inc VEEA.OQ, up 47.3%
** OFA Group OFAL.OQ, up 34.3%
The top three Nasdaq .PL.O percentage losers:
** China SXT Pharmaceuticals Inc SXTC.OQ, down 60.2%
** DarkIris Inc DKI.OQ, down 51.5%
** Moolec Science SA MLEC.OQ, down 50.0%
** T-Mobile US Inc TMUS.O:
BUZZ - European telecom shares fall after SpaceX spectrum deal nL6N45V0EH
** Space Exploration Technologies Corp SPCX.O:
BUZZ - Climbs after deal to acquire nationwide low-band spectrum portfolio nL4N45V0KP
** Humana Inc HUM.N:
BUZZ - Rises on higher Medicare Advantage ratings [nL4N45V0LU
** Definium Therapeutics Inc DFTX.O:
BUZZ - Up as J.P.Morgan starts with 'overweight' rating on LSD-based therapy nL4N45V14O
** UnitedHealth Group Inc UNH.N:
BUZZ - TD Cowen cuts UnitedHealth PT ahead of Q3 results nL4N45V0OU
** Newmont Corp NEM.N:
** Gold Fields Ltd GFI.N:
** Harmony Gold Mining Co Ltd HMY.N:
** AngloGold Ashanti PLC AU.N:
BUZZ - Gold miners rise as bullion prices edge up on softer US dollar nL4N45V0PG
** Delta Air Lines Inc DAL.N:
BUZZ - Drops after slashing full-year profit forecast nL4N45V11Q
** Apple Inc AAPL.O:
BUZZ - Falls on report of iPhone production cuts nL4N45V0SB
** Crescent Energy Company CRGY.N:
BUZZ - Falls on $1 bln equity raise for Devon deal nL6N45V0J4
** Medtronic PLC MDT.N:
** Tandem Diabetes Care Inc TNDM.O:
** PROCEPT BioRobotics Corp PRCT.O:
** Insulet Corp PODD.O:
BUZZ - MedTech growth concerns likely to overshadow Q3 results, Leerink says nL4N45V0YE
** Lumentum Holdings Inc LITE.O:
BUZZ - Rises after report AI-server optical products sold out into 2029 nL4N45V0ZY
** Crown Castle Inc CCI.N:
** American Tower Corp AMT.N:
** SBA Communications Corp SBAC.O:
BUZZ - US cell tower operators surge on SpaceX spectrum acquisition nL6N45V0QM
** AbbVie Inc ABBV.N:
BUZZ - UBS lifts AbbVie target as focus expands beyond immunology drugs nL4N45V14D
** VF Corp VFC.N:
BUZZ - Rises after JP Morgan upgrades to 'neutral' nL6N45V0SN
** Biogen Inc BIIB.O:
BUZZ - UBS lifts Biogen PT on late-stage pipeline catalysts; shares rise nL4N45V166
Index RIC | Index name | Percent change % |
.SPX | S&P 500 | 0.54 |
.SPLRCT | S&P 500 Information Technology | 0.29 |
.SPLRCU | S&P 500 Utilities | 0.67 |
.SPLRCD | S&P 500 Consumer Discretionary | 1.28 |
.SPLRCM | S&P 500 Materials | 0.85 |
.SPLRCI | S&P 500 Industrials | 0.44 |
.SPLRCL | S&P 500 Communication Services (Sector) | -0.15 |
.SPSY | S&P 500 Financials | 0.78 |
.SPLRCR | S&P 500 Real Estate | 1.59 |
.SPXHC | S&P 500 Health Care | 1.55 |
.SPLRCS | S&P 500 Consumer Staples | 0.05 |
.SPNY | S&P 500 Energy | 0.18 |
(Compiled by Rajarshi Roy and Sanskriti Shekhar)
((Rajarshi.Roy@thomsonreuters.com))
Recent news on AbbVie
See all newsBrief: Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer
Eli Lilly hits record high as healthcare stocks rally
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96